Janux Therapeutics Inc (JANX)
48.90
-1.41
(-2.80%)
USD |
NASDAQ |
Nov 25, 16:00
48.90
0.00 (0.00%)
After-Hours: 20:00
Janux Therapeutics Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2021
--
Maximum
Mar 2021
--
Average
--
Median
Mar 2021
Debt to Equity Ratio Benchmarks
| Dynavax Technologies Corp | 0.3281 |
| OPKO Health Inc | 0.3142 |
| Krystal Biotech Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Palatin Technologies Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 695.02M |
| Total Liabilities (Quarterly) | 38.92M |
| Shareholders Equity (Quarterly) | 656.10M |
| Current Ratio | 38.80 |